Rare lncRNA LINC01235 Discovery Opens Path to Targeted TNBC Therapies

Researchers can now pursue preclinical lncRNA-based therapies after confirming LINC01235’s role in driving NFIB expression through the NOTCH pathway in aggressive triple-negative tumors.